Active Pharmaceutical Ingredients Market by API Synthesis (Biotech API, Synthetic Chemical API, and HPAPI), by Type of Manufacturing (Contract Manufacturing and In-House API Manufacturing), by Type of API (Synthetic API and Biological API), by Drug type (Into Branded Drugs, Generic Drugs and OTC Drugs), for Cardiology, Oncology, Anti-Inflammatory, Gastrointestinal and Other Application - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Global active pharmaceutical ingredient market to reach USD 213.84 billion in 2021 and is growing at a CAGR of 6.3% during 2016-2021

02-Aug-2016 | Number of pages: 110 | Report Code: ZMR-56 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the active pharmaceutical ingredient market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the active pharmaceutical ingredient along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the active pharmaceutical ingredient market on a global level.

In order to give the users of this report a comprehensive view on the active pharmaceutical ingredient market, we have included a detailed segmentation of active pharmaceutical ingredient. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the active pharmaceutical ingredient market has also been included. The study encompasses a market attractiveness analysis, wherein type segments and application segments are benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view on the active pharmaceutical ingredient market by segmenting the market based on API synthesis, biotech API, synthetic chemical API and HPAPI. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The active pharmaceutical ingredient market’s manufacturing type segment includes contract manufacturing and in-house API manufacturing. The drug type segment includes branded drugs, generic drugs, and OTC drugs. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific and Rest of the world. This segmentation includes demand for active pharmaceutical ingredient based on individual applications in all the regions.

The key players active in this market are Sun Pharmaceuticals Industries Limited, Novartis International AG, BASF SE, Pfizer, Inc., Aurobindo, Albemarle Corporation, and Boehringer Ingelheim among others.

The report segments the global active pharmaceutical ingredient market as

Active Pharmaceutical Ingredient Market: API Synthesis Segment Analysis

  • Biotech API
  • Synthetic Chemical API
  • HPAPI

Active Pharmaceutical Ingredient Market: Type of Manufacturing Segment Analysis

  • Contract Manufacturing
  • In-House API Manufacturing

Active Pharmaceutical Ingredient Market: Type of API Segment Analysis

  • Synthetic API
  • Biological API

Active Pharmaceutical Ingredient Market: Drug Type Segment Analysis

  • Branded Drugs
  • Generic Drugs
  • OTC Drugs

Active Pharmaceutical Ingredient Market: Therapeutic Application Segment Analysis

  • Cardiology
  • Oncology
  • Anti-Inflammatory
  • Gastrointestinal 
  • Other

Related Reports

Contrast Media/Contrast Agent Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1359 | Report Format:

Global Contrast Media/Contrast Agent Market: Overview To enhance the contrast of the structures or fluids inside the body contrast medium or the contrast agent is used in the medical imaging. The anatomical organs and structures are imaged better as the image contrast is increased. Thus, it is v...Read More

Continuous Renal Replacement Therapy (CRRT) Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1358 | Report Format:

Global Continuous Renal Replacement Therapy (CRRT) Market: Overview A process wherein extracorporeal blood purification is done to substitute for the renal dysfunction for an extended period of time is known as continuous renal replacement therapy (CRRT). It is a therapy of renal replacement for...Read More

Superdisintegrants Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1354 | Report Format:

Global Superdisintegrants Market: Overview Superdisintegrant is a kind of excipient that is used for the tablet-based drug delivery in the pharmaceutical industry. To help the solid dosage form drugs such as pills or tablets disintegrate when they are submerged in the liquid superdisintegrants a...Read More

Medication Management Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1349 | Report Format:

Global Medication Management Market: Overview To manage and support the medicine management cycle an advanced system is developed known as medication management. In the hospitals, the medication management system is used for prescribing, supplying and administering the medicines. The use of the ...Read More

Hepatitis C Drug Market for Hospitals, Private labs, Physician Offices, Public Health Labs and Blood Banks - Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022

Mar-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-1326 | Report Format:

The report covers forecast and analysis for the Hepatitis C drug market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based on revenue (USD Billion). The study includes drivers and restraints for the Hepatitis C drug market along w...Read More

Choose License Type: